SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 209 filers reported holding SAGE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,990,274 | -54.3% | 145,300 | +4.5% | 0.04% | -59.8% |
| Q2 2023 | $6,540,717 | +13.7% | 139,105 | +1.5% | 0.09% | +8.8% |
| Q1 2023 | $5,752,590 | +12.0% | 137,097 | +1.8% | 0.08% | 0.0% |
| Q4 2022 | $5,136,161 | -4.3% | 134,666 | -50.8% | 0.08% | +31.1% |
| Q3 2022 | $5,364,359 | +18.4% | 273,714 | +95.2% | 0.06% | -32.2% |
| Q2 2022 | $4,529,000 | +615.5% | 140,202 | +1157.9% | 0.09% | +1400.0% |
| Q2 2021 | $633,000 | -85.2% | 11,146 | -81.1% | 0.01% | -92.3% |
| Q4 2019 | $4,263,000 | +203.8% | 59,047 | +490.5% | 0.08% | +100.0% |
| Q3 2019 | $1,403,000 | +382.1% | 10,000 | +446.4% | 0.04% | +254.5% |
| Q1 2019 | $291,000 | +5.1% | 1,830 | -6.8% | 0.01% | +10.0% |
| Q3 2018 | $277,000 | +6.9% | 1,963 | +22.2% | 0.01% | -47.4% |
| Q1 2018 | $259,000 | – | 1,606 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |